id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0902-0001,FDA,FDA-2011-N-0902,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Prescription Drug Product Labeling; Medication Guide Requirements",Notice,60 Day Proposed Information Collection,2011-12-21T05:00:00Z,2011,12,2011-12-21T05:00:00Z,2012-02-22T04:59:59Z,2011-12-21T21:40:13Z,2011-32548,0,0,0900006480f87038